Carregant...

Tumor Necrosis Factor α-Converting Enzyme Inhibition Reverses Hepatic Steatosis and Improves Insulin Sensitivity Markers and Surgical Outcome in Mice

BACKGROUND: Hepatic steatosis is an established risk factor for complications following major hepatic resection. Pharmacological options to reverse steatosis prior to surgery, however, are lacking. We hypothesized that treatment with the pharmacologic tumor necrosis factor-α converting enzyme (TACE)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: de Meijer, Vincent E., Le, Hau D., Meisel, Jonathan A., Sharma, Anisha K., Popov, Yury, Puder, Mark
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3181348/
https://ncbi.nlm.nih.gov/pubmed/21980496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0025587
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!